Gamida Cell
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-22-012318
- Document
- 8-K
- Exhibit 99.1
- Press release, dated March 15, 2022
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX
